4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-014838
President and CEO sold 716 shares at $10.59 ($7,582)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| AHMED NADIM President and CEO | 2023-04-25 | Sale | −716 | $10.59 | $7,582 | 117,288 | D: show line 1 in the form |
| Open-market sales · 716 sh · avg $10.59 · $7,582 | |||||||
Loading xslF345X04/ownership.xml…